@This study see@ms fascinating, demonstrating the potential of rescue cyclophosphamide treatment in managing relapse-associated disability in #MultipleSclerosis. It's intriguing to see the span over 15 years; what criteria were used to determine the effectiveness of the treatment? Were there any significant side effects noted in the cohort? Understanding such aspects will help us better interpret the overall impact of this treatment. For those diving deeper into related biomedical inquiries, Sci-Quest is a valuable resource for generating detailed reviews. Check it out at sciqst.com. #Medicine

Rescue cyclophosphamide treatment was used in 23 people with #MultipleSclerosis from 2009 to 2024, and was associated with improvement in relapse-associated disability. 🔓MSJ-ETC study from@UBC ▶️journals.sagepub.com/doi/full/10.11…e2

Save this for awareness, share it with someone who needs to know, and follow for more MS facts that matter. 🔗livewithms.com2 #MultipleSclerosis #MSAwareness #ChronicIllness #InvisibleIllness #MSCommunity #AutoimmuneDisease #HealthEducation #Genetics #LiveWithMS

Farrah J. Mateen, MD, PhD, discusses clinical considerations for subcutaneous #ocrelizumab. breakthroughsforphysicians.nm.org/neurosciences-… #MultipleSclerosis #ClinicalResearch #NeuroImmunology #NeuroInnovation

In a case–control study on viruses and #MultipleSclerosis run in 2003, one person already had intrathecal synthesis of Epstein-Barr virus antibodies 15 years before clinical onset of #MultipleSclerosis. @MSJ_Research journals.sagepub.com/doi/abs/10.117… 1/🧵journals.sagepub.com/doi/abs/10.117…f

Intestinal epithelial cells upregulate MHC II and induce pathogenic T cells that migrate to the CNS, promoting symptoms of #MultipleSclerosis in mouse models. Learn more in Science #Immunology: scim.ag/4rT0HuP #IECs

✨ Read more: 👉livewithms.com/blogs/blog/hea…7 Save & share with someone who may need this today. #LiveWithMS #MultipleSclerosis #MentalHealthSupport #ChronicIllness #HealingJourney #WellnessWithMS #YouAreNotAlone

March is #MSAwarenessMonth, a time to shed light on a chronic condition that affects at least 2.8M people worldwide. Visit BarrowNeuro.org/MS to learn more about our #MultipleSclerosis Program, the 1st & only Center for Comprehensive Care in #AZ designated by the @mssociety.

My new Amazon delivery arrived just in time for tomorrow’s MS Fest! amazon.com/are-TRK-Long-S… #NeverStopNeverQuitForThem #MultipleSclerosis #MS #ThisisMS #nationalmssociety

Well I must admit, #multiplesclerosis did strike me down yesterday. At the end of a perfect day, it destroyed everything. Today, I still feel terrible. What to do? #lifting in the weight room to #feelbetter . MS never gives up; Neither do I!

At the infusion centre. #Ocrevus time. #MultipleSclerosis

Congratulations again to @Msassociation on last year’s award-winning submission! Spring 2026 session deadline closes at midnight PST tonight. digitalhealthawards.com #MS #MultipleSclerosis #MSCommunity #MSSupport #VitalServices #ImprovingLivesToday

Past evidence has established many benefits related to improved cardiorespiratory fitness in people with #multiplesclerosis. However, the research among those with advanced MS remains limited. Read more in Multiple Sclerosis and Related Disorders: doi.org/10.1016/j.msar…

realtalkms.com/447 🥗 The MIND diet continues to gain attention for its potential impact on brain health. We explain what researchers are seeing—and why it matters in MS on RealTalk MS. #MultipleSclerosis #RealTalkMS #MSResearch #MindDiet

While current #MultipleSclerosis (#MS) drugs are 98% effective at stopping relapses for patients with relapsing-remitting MS, they are only a part of managing the disease. Certain habits may help patients with relapsing-remitting MS manage their health. yalemedicine.org/news/how-to-ma…

New online! 🤔Could gut-targeted immune therapy, such as #vedolizumab, reduce the risk of #MultipleSclerosis? 📊Afsaneh Shirani and Olaf Stuve analysed health records of over 2 million people to investigate the role of T cell licensing pathways in MS:journals.sagepub.com/doi/full/10.11…PkE6

MS cases have doubled in England over the past two decades, but people diagnosed more recently are living longer, data show. buff.ly/BmqISwQ #MultipleSclerosis #MSTreatment #MSResearch #MSNews

Advances in diagnostics and disease-modifying therapies have expanded treatment options for #multiplesclerosis over the past two decades. We spoke with Dr. Jonathan R. Doty of the Michigan Institute for Neurological Disorders to find out how. vist.ly/4wcwq

Save this if you relate, share to raise awareness, and follow for more truths about living with MS. 🔗livewithms.com2 #MultipleSclerosis #MSAwareness #InvisibleIllness #ChronicIllness #MSCommunity #AutoimmuneDisease #LiveWithMS #HealthEducation #DisabilityAwareness

Guest writer Tyler Dukes, who has SMA, shares how he formed a deep connection with his aunt, who has MS, based on mutual understanding. buff.ly/YBYt3GB #MultipleSclerosis #MSTreatment #MSResearch #MSNews